GH Optimization Stack
Pulsatile, natural GH stimulation
Combines a GHRH analog with a GHRP for synergistic GH release without side effects.
How this works
CJC-1295 binds the GHRH receptor on the anterior pituitary, increasing GH synthesis. Ipamorelin acts on the ghrelin receptor (GHSR1a) to trigger GH release pulses. Together they amplify each other while avoiding cortisol/prolactin elevation.
The synergy
GHRH and GHS receptors are separate pathways but both control GH release. Activating both creates 5-10x larger GH pulses than either alone. Ipamorelin's selectivity prevents side effects common with older GHRPs.
How researchers run it
Each compound, explained
CJC-1295
Synthetic GHRH analog. Stimulates natural GH release.
GHRH receptor agonist. Stimulates anterior pituitary to release GH.
Minimal. Occasional flushing at injection site.
Ipamorelin
Selective ghrelin receptor agonist. Cleanest GH stimulator for research.
Ghrelin receptor (GHSR1a) agonist. Pulsatile GH release without cortisol/prolactin increase.
Very low side effect profile.
